Trial intelligence / Profile preview

Rosiglitazone versus metformin in non-obese women with polycystic ovary syndrome and metabolic disorders

ChiCTR-TRC-13003529Phase 4Completed

Sponsor
West China Second University Hospital
Start
Oct 2013
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial in polycystic ovary syndrome (PCOS) comparing Metformin with Rosiglitazone (2 arms). Primary endpoint: HOMA-IR. Started Oct 2013; status: completed.

02

Drugs

metforminrosiglitazone
03

Conditions

polycystic ovary syndrome (PCOS)

Beyond the preview

Go deeper on ChiCTR-TRC-13003529.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR-TRC-13003529.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call